Unveiling the Burden of Leukemia in Eritrea (2010-2020): Chronic Leukemia Stability, Rising ALL Incidence, and the
Daniel Mebrahtu Abraha1, Samuel Tekle Mengistu2, Efriem Ghirmay3
1Hematology, National Health Laboratory, Asmara, Eritrea.
Background And Aims:
Little research has been conducted on the epidemiology of leukemia in Eritrea. In this retrospective study, we evaluated the burden and trends of acute lymphoblastic leukemia (ALL), acute myelogenous leukemia (AML), chronic myelogenous leukemia (CML), chronic lymphocytic leukemia (CLL), and overall leukemia in Eritrea.
Methods And Results:
An audit of leukemia cases recorded in laboratory logbooks at the National Health Laboratory and Orotta Referral and Teaching Hospital between January 2010 and December 2020 was performed. In addition to leukemia subtypes, variables such as age, sex, and year of incidence were retrieved. Relevant estimates assessed included crude incidence rates (CIR), age-standardized rates (ASIR), and estimated annual percentage change (EAPC). In total, 372 confirmed cases of leukemia were recorded between 2010 and 2020. The median (interquartile range [IQR]) age, maximum-minimum age, and male-to-female ratio were as follows: 48 years (24.5-60 years), 2-91 years, and 210:161 (1.3:1), respectively. The estimated all-age CIR and ASIR over the study period were 9.22 per 100,000 and 30.1 per 100,000, respectively. Analysis of cumulative (2010-2020) CIR per 100,000 (ASIR per 100 000) for ALL, AML, CLL, and CML were as follows: 2.01 (3.87); 0.94 (2.38); 2.94 (15.37); and 3.61 (24.03). Additionally, the median (IQR) age differed significantly across leukemia subtypes: ALL (23.0 years, IQR: 10.0-39.0); AML (30 years, IQR: 20-56 years); CLL (59.0 years, IQR: 40.75-66.75 years); and CML (49 years, IQR: 39.25-60 years), p value (Kruskal-Wallis) < 0.05. The proportion of leukemia types did not differ significantly between males and females. Unlike other leukemia subtypes, the evaluation of ALL's EAPC demonstrated that the incidence of leukemia increased over time, 21.9 (95% CI: 3.1-44.1), p value = 0.025.
Conclusions:
The burden of leukemia in Eritrea remained relatively stable. However, due to underreporting and underdiagnosis, we believe the true burden of leukemia is likely higher. Furthermore, an upward trend in the burden of ALL was observed. Lastly, expanding diagnostic services to other sub-zones, establishing a national cancer registry, and prioritizing research remain critical in Eritrea.
Related Concept Videos
01:27Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
01:14Erythropoiesis
01:27Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:22Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
01:24Chronic Kidney Disease II: Clinical Manifestations